GLP-1, incretin multi-agonist and amylin trial starts by region
3 regions, 2020 to 2025
223
Global, 2025
GLP-1, incretin multi-agonist and amylin trial starts by region: 3 regions, 2020 to 2025
GLP-1, incretin multi-agonist and amylin trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 16 to 223. Latest values: Global 223 (2025); United States 107 (2025); China 54 (2025).
0
50
100
150
200
250
2020
2021
2022
2023
2024
2025
Global
United States
China
GLP-1, incretin multi-agonist and amylin trial starts by region: 3 regions, 2020 to 2025
GLP-1, incretin multi-agonist and amylin trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 16 to 223. Latest values: Global 223 (2025); United States 107 (2025); China 54 (2025).
0
100
200
300
2020
2021
2022
2023
2024
2025
Global
United States
China
GLP-1, incretin multi-agonist and amylin trial starts by region: 3 regions, 2020 to 2025
GLP-1, incretin multi-agonist and amylin trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 16 to 223. Latest values: Global 223 (2025); United States 107 (2025); China 54 (2025).
0
100
200
300
2020
2021
2022
2023
2024
2025
Global
United States
China
View the underlying data
GLP-1, incretin multi-agonist and amylin trial starts by region: 3 regions, 2020 to 2025
Region
Period
Type
Value
Global
2025
Actual
223
Global
2024
Actual
191
Global
2023
Actual
142
Global
2022
Actual
104
Global
2021
Actual
101
Global
2020
Actual
66
United States
2025
Actual
107
United States
2024
Actual
98
United States
2023
Actual
70
United States
2022
Actual
42
United States
2021
Actual
51
United States
2020
Actual
20
China
2025
Actual
54
China
2024
Actual
36
China
2023
Actual
40
China
2022
Actual
21
China
2021
Actual
18
China
2020
Actual
16
Chart:
StatOrigin
· Source: ClinicalTrials.gov ·
statorigin.org
CC BY 4.0